1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with morphine in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esplugues, JV; Pique, JM; Whittle, BJ | 1 |
| Burde, R; Schultz, G; Seifert, R | 1 |
| Esplugues, JV; Moncada, S; Whittle, BJ | 1 |
| Dohi, T; Kitayama, T; Morita, K; Motoyama, N; Shiraishi, S | 1 |
| Akisu, C; Akisu, M; Berdeli, A; Dagci, T; Kultursay, N; Yalaz, M | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and morphine
| Article | Year |
|---|---|
Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF.
Topics: Animals; Blood Pressure; Capsaicin; Female; Gastric Mucosa; Male; Microcirculation; Morphine; Naloxone; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Regional Blood Flow | 1990 |
Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells.
Topics: Adenosine Triphosphate; Alprostadil; Biotransformation; Endorphins; Enkephalin, Methionine; Humans; In Vitro Techniques; Leukemia, Experimental; Morphine; N-Formylmethionine Leucyl-Phenylalanine; Naloxone; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Superoxides; Tumor Cells, Cultured | 1989 |
Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.
Topics: Animals; Capsaicin; Infusions, Intra-Arterial; Male; Morphine; Narcotics; Neurons, Afferent; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stomach Ulcer; Tetrodotoxin | 1989 |
[Pain relieving effect of platelet-activating factor (PAF) antagonists in a bone cancer pain model].
Topics: Animals; Bone Neoplasms; Disease Models, Animal; Femur; Humans; Morphine; Pain; Pain Management; Palliative Care; Platelet Activating Factor | 2015 |
Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
Topics: Animals; Animals, Newborn; Calcimycin; Cells, Cultured; Female; Lipopolysaccharides; Macrophages, Alveolar; Male; Meconium; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2004 |